(Q40269934)

19 September 2017

title

Prevalence of vaccine-derived polioviruses in stools of immunodeficient children in South Africa (English)

1 reference

19 September 2017

0 references

0 references

Pavlov DN

1

1 reference

19 September 2017

Van Zyl WB

2

1 reference

19 September 2017

Van Heerden J

3

1 reference

19 September 2017

Kruger M

4

1 reference

19 September 2017

Blignaut L

5

1 reference

19 September 2017

Grabow WO

6

1 reference

19 September 2017

Ehlers MM

7

1 reference

19 September 2017

publication date

1 December 2006

1 reference

Journal of Applied Microbiology

19 September 2017

published in

1 reference

19 September 2017

volume

101

1 reference

19 September 2017

issue

6

1 reference

19 September 2017

page(s)

1367-1379

1 reference

Evolution of poliovirus type I during 5.5 years of prolonged enteral replication in an immunodeficient patient

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03020.X

Nucleotide variation in Sabin type 2 poliovirus from an immunodeficient patient with poliomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03020.X

Paralytic poliomyelitis associated with live oral poliomyelitis vaccine in child with HIV infection in Zimbabwe: case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03020.X

Polio eradication: the OPV paradox

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03020.X

Evolutionary trees from DNA sequences: A maximum likelihood approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03020.X

Transmissibility and persistence of oral polio vaccine viruses: implications for the global poliomyelitis eradication initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03020.X

Evolution of circulating wild poliovirus and of vaccine-derived poliovirus in an immunodeficient patient: a unifying model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03020.X

Natural genetic exchanges between vaccine and wild poliovirus strains in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03020.X

Evolution of wild-type 1 poliovirus in two healthy siblings excreting the virus over a period of 6 months

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03020.X

Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03020.X

Serial recombination during circulation of type 1 wild-vaccine recombinant polioviruses in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03020.X

Characterization of CHAT and Cox type 1 live-attenuated poliovirus vaccine strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03020.X

Evolution of the Sabin strain of type 3 poliovirus in an immunodeficient patient during the entire 637-day period of virus excretion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03020.X

The vaccine origin of the 1968 epidemic of type 3 poliomyelitis in Poland.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03020.X

Isolation of an intertypic poliovirus capsid recombinant from a child with vaccine-associated paralytic poliomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03020.X

Effect of different immunisation schedules on the excretion and reversion of oral poliovaccine strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03020.X

Recombinant vaccine-derived poliovirus in Madagascar

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03020.X

Community-acquired poliovirus infection in children with primary immunodeficiencies in Tunisia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03020.X

Towards global poliomyelitis eradication: the successes and challenges for a developed country

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03020.X

Structural comparison of the Autographa californica nuclear polyhedrosis virus-induced RNA polymerase and the three nuclear RNA polymerases from the host, Spodoptera frugiperda

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03020.X

Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03020.X

"Endgame" Issues for the Global Polio Eradication Initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2672.2006.03020.X

10.1111/J.1365-2672.2006.03020.X

21 January 2018

Identifiers

DOI

1 reference

19 September 2017

1 reference